The incorporation of nanomaterials into products can improve performance, efficiency, and durability in various fields ranging from construction, energy management, catalysis, microelectronics, plastics, coatings, and paints to consumer articles such as foods and cosmetics. But innovation never comes at zero risk. The potential hazards resulting from human exposure during production, use, or disposal has raised concerns and targeted research early on. Safety of Nanomaterials along Their Lifecycle: Release, Exposure, and Human Hazards presents the state of the art in nanosafety research from a lifecycle perspective. Although major knowledge gaps still exist, solid data are now available to identify scenarios of critical risk as well as those of safe nanomaterial use for our benefit. The book is divided into four parts: characterization, hazard, release and exposure, and real-life case studies. To improve coherence throughout the book, various chapters review the same suite of well-characterized, judiciously chosen, and identical industrial nanomaterials. The book is a helpful resource to professionals in product development, industrial design, regulatory agencies, and materials scientists and engineers involved in the safety of nanomaterials.
Format: Hardback
CONTRIBUTORS: Wendel Wohlleben
EAN: 9781466567863
COUNTRY: United States
PAGES:
WEIGHT: 907 g
HEIGHT: 234 cm
PUBLISHED BY: Taylor & Francis Inc
DATE PUBLISHED: 2014-12-03
CITY:
GENRE: SCIENCE / Chemistry / General
WIDTH: 156 cm
SPINE:
Book Themes:
Biochemistry
Edited byWendel Wohlleben, Advanced Materials and Systems Research, Department of Material Physics, BASF SE, Ludwigshafen, GermanyThomas A.J. Kuhlbusch, Air Quality and Sustainable Nanotechnology Unit, Institute of Energy and Environmental Technology (IUTA) e.V, Duisburg, GermanyJürgen Schnekenburger, Biomedical Technology Center, Westfälische Wilhelms-Universität, Münster, GermanyClaus-Michael Lehr, Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) Helmholtz Centre for Infection Research (HZI) and Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany